The host-microbe interface within the gut

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 16, Issue 6, 2002, Pages 915-931

  Shanahan, Fergus ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Bacterial flora; Commensal bacteria; Crohn's disease; Lymphocyte; Mucosal immunity; Probiotics; Ulcerative colitis

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL METABOLISM; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BIOME; COMMENSALISM; DIGESTIVE SYSTEM INFLAMMATION; ENTERITIS; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TUMOR; HUMAN; HUMAN GENOME; IMMUNE SYSTEM; IMMUNOSTIMULATION; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE MUCOSA; LIVER; NONHUMAN; ORGANISMAL INTERACTION; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; ANIMAL; BACTERIAL TRANSLOCATION; GERMFREE ANIMAL; INTESTINE; MICROBIOLOGY; MUCOSAL IMMUNITY; BACTERIAL FLORA; BACTERIAL TRANSMISSION; CLOSTRIDIUM DIFFICILE; DRUG EFFICACY; GENETIC SUSCEPTIBILITY; HELICOBACTER PYLORI; ILEITIS; IMMUNOREACTIVITY; INTESTINE CANCER; INTESTINE INFECTION; LACTOCOCCUS LACTIS; LIVER METABOLISM; MICROENVIRONMENT; PUBLIC HEALTH; RNA SEQUENCE; STOMACH ACID; ULCERATIVE COLITIS;

ANIMALS; BACTERIAL TRANSLOCATION; GERM-FREE LIFE; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; INTESTINES;

CORTICOSTEROID; MESALAZINE; PROBIOTIC AGENT;

EID: 0036885585     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2002.0342     Document Type: Article

References (97)

1. Shanahan, F (2000). Mechanisms of immunologic sensation of intestinal contents. American Journal of Physiology, Gastrointestinal and Liver Physiology, 278 G191-G196.
2. MacDonald, T T, & Pattersson, S (2000). Bacterial regulation of intestinal immune responses. Inflammatory Bowel Diseases, 6 116-122.
3. Berg, R D (1996). The indigenous gastrointestinal microflora. Trends in Microbiology, 4 430-435.
4. French, N, & Pettersson, S (2000). Microbe-host interactions in the alimentary tract: the gateway to understanding inflammatory bowel disease. Gut, 47 162-163.
5. Bocci, V (1992). The neglected organ: bacterial flora has a crucial immunostimulatory role. Perspectives in Biology and Medicine, 35 251-260.
6. Bengmark, S (1998). Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut, 42 2-7.
7. Gordon, J I, Hooper, L V, & McNevin, S M et al. (1997). Epithelial cell growth and differentiation. III. Promoting diversity in the intestine: conversations between the microflora, epithelium, and diffuse GALT. American Journal of Physiology, Gastrointestinal and Liver Physiology, 273 G565-G570.
8. Hooper, L V, & Gordon, J I (2001). Commensal host-bacterial relationships in the gut. Science, 292 1115-1118.
9. Van de Merwe, J P, Stegeman, J H, & Hazenberg, M P (1983). The resident faecal flora is determined by genetic characteristics of the host. Implications for Crohn's disease?. Antonie van Leeuwenhoek, 49 119-124.
10. Borriello, S P, Hudson, M, & Hill, M (1978). Investigation of the gastrointestinal bacteria flora. Clinics in Gastroenterology, 7 329-349.
11. Vaughan, E E, Schut, F, & Heilig, H GH J et al. (2000). A molecular view of the intestinal ecosystem. Current Issues in Intestinal Microbiology, 1 1-12.
12. Akkermans, A DL, Zoetendal, E G, & Favier, C F et al. (2000). Temperature and denaturing gradient gel electrophoresis analysis of 16S rRNA from human faecal samples. Bioscience Microflora, 19 93-98.
13. Qiu, X, Wu, L, & Huang, L et al. (2001). Evaluation of PCR-generated chimeras, mutations, and heteroduplexes with 16S rRNA gene based cloning. Applied Environmental Microbiology, 67 880-887.
14. Dalwadi, H, Wei, B, & Braun, J (2000). Defining new pathogens and non-culturable infectious agents. Current Opinion in Gastroenterology, 16 56-59.
15. Cohavy, O, Bruckner, D, & Gordon, L K et al. (2000). Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infection and Immunity, 68 1542-1548.
16. Wei, B, Dalwadi, H, & Gordon, L K et al. (2001). Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody. Infection and Immunity, 69 6044-6054.
17. Dalwadi, H, Wei, B, & Kronenberg, M et al. (2001). The Crohn's disease-associated bacterial protein I2 is a novel enteric T cell superantigen. Immunity, 15 149-158.
18. Sutton, C L, Kim, J, & Yamane, A et al. (2000). Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology, 119 23-31.
19. Macdonald, T T, & Carter, P B (1979). Requirement for a bacterial flora before mice generate cells capable of mediating the delayed hypersensitivity reaction to sheep red blood cells. Journal of Immunology, 122 2426-2429.
20. Rook, G AW, & Stanford, J L (1998). Give us this day our daily germs. Immunology Today, 19 113-116.
21. MacDonald, T T, & Monteleone, G (2001). Interleukin-12 and Th1 immune responses in human Peyer's patches. Trends in Immunology, 22 244-247.
22. Midtvedt, T (1999). Microbial functional activities. In L A Hanson, & R H Yolken (Eds.), Intestinal Microflora, 79-96. Philadelphia: Lippincott-Raven.
23. Dugas, B, Mercenier, A, & Lenoir-Wijnkoop, I et al. (1999). Immunity and probiotics. Immunology Today, 20 387-390.
24. Berg, R D (1999). Bacterial translocation from the gastrointestinal tract. Advances in Experimental Medicine and Biology, 473 11-30.
25. Neutra, M R (1988). Role of M cells in transepithelial transport of antigens and pathogens to the mucosal immune system. American Journal of Physiology, Gastrointestinal and Liver Physiology, 274 G785-G791.
26. Kagnoff, M F, & Eckmann, L (1997). Epithelial cells as sensors for microbial infection. Journal of Clinical Investigation, 100 6-10.
27. Ouellette, A J (1999). Paneth cell antimicrobial peptides and the biology of the mucosal barrier. American Journal of Physiology, Gastrointestinal and Liver Physiology, 277 G257-G261.
28. Rescigno, M, Urbano, M, & Valzasina, B et al. (2001). Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunology, 2 361-367.
29. Huang, Q, Liu, D, & Majewski, P et al. (2001). The plasticity of dendritic cell responses to pathogens and their components. Science, 294 870-875.
30. Iwasaki, A, & Kelsall, B L (1999). Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. Journal of Experimental Medicine, 190 229-239.
31. Anton, P, O'Connell, J, & O'Connell, D et al. (1998). Mucosal binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP). Gut, 42 374-379.
32. Akira, S, Takeda, K, & Kaisho, T (2001). Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunology, 2 675-680.
33. Cario, E, Rosenberg, I M, & Brandwein, S L et al. (2000). Lipopolysaccharide activates distinct signalling pathways in intestinal epithelial cell lines expressing Toll-like receptors. Journal of Immunology, 164 966-972.
34. Cario, E, & Podolsky, D K (2000). Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infection and Immunity, 68 7010-7017.
35. Krieg, A M, & Wagner, H (2000). Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA. Immunology Today, 21 521-526.
36. Hemmi, H, Takeuchi, O, & Kawai, T et al. (2000). A Toll-like receptor recognizes bacterial DNA. Nature, 408 740-745.
37. Bauer, S, Kirschning, C J, & Hacker, H et al. (2001). Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proceedings of the National Academy of Sciences of the USA, 98 9237-9242.
38. Elewaut, D, DiDonato, J A, & Kim, J M et al. (1999). NF-κB is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. Journal of Immunology, 163 1457-1466.
39. ++-mediated activation of the NF-κB pathway. Journal of Clinical Investigation, 105 79-92.
40. Neish, A S, Gewirtz, A T, & Zeng, H et al. (2000). Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science, 289 1560-1563.
41. Shanahan, F (2002). Crohn's disease. Lancet, 359 62-69.
42. Boirivant, M, Marini, M, & Di Felice, G et al. (1999). Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation s how defective CD2 pathway-induced apoptosis. Gastroenterology, 116 557-565.
43. Ina, K, Itoh, J, & Fukushima, K et al. (1999). Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. Journal of Immunology, 163 1081-1090.
44. Atreya, R, Mudter, J, & Finotto, S et al. (2000). Blockade of interleukin 6 trans signalling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn's disease and experimental colitis in vivo. Nature Medicine, 6 583-588.
45. Maloy, K J, & Powrie, F (2001). Regulatory T cells in the control of immune pathology. Nature Immunology, 2 816-822.
46. Powrie, F (1995). T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity, 3 171-174.
47. Kronenberg, M, & Cheroutre, H (2000). Do mucosal T cells prevent intestinal inflammation?. Gastroenterology, 118 974-977.
48. Read, S, Malmström, V, & Powrie, F (2000). Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. Journal of Experimental Medicine, 192 295-302.
49. Bomsel, M (1997). Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nature Medicine, 3 42-47.
50. + cells. Nature Medicine, 8 150-156.
51. Higgins, L M, Frankel, G, & Connerton, I et al. (1999). Role of bacterial intimin in colonic hyperplasia and inflammation. Science, 285 588-591.
52. Meijer, L K, Schesser, K, & Wolf-Watz, H et al. (2000). The bacterial protein YopJ abrogates multiple signal transduction pathways that converge on the transcription factor CREB. Cell Microbiology, 2 231-238.
53. McCole, D F, Eckmann, L, Laurent, F, & Kagnoff, M F (2000). Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection. Infection and Immunity, 68 1710-1713.
54. Fan, T, Lu, H, & Hu, H et al. (1998). Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. Journal of Experimental Medicine, 187 487-496.
55. O'Boyle, C J, MacFie, J, & Mitchell, C J et al. (1988). Microbiology of bacterial translocation in humans. Gut, 42 29-35.
56. Shanahan, F, & Targan, S (1999). Immunologic diseases: gastrointestinal manifestations of immunodeficiency, hypersensitivity, and graft versus host disease. In T Yamada, D Alpers, & C Owyang (Eds.), Textbook of Gastroenterology, 2547-2563. Philadelphia: JB Lippincott Company.
57. Shiloh, M U, MacMicking, JD, & Nicholson, S et al. (1999). Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity, 10 29-38.
58. Shanahan, F (2000). Probiotics and inflammatory bowel disease: is there a scientific rationale?. Inflammatory Bowel Disease, 6 107-115.
59. Shanahan, F (2001). Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology, 120 622-635.
60. Blumberg, R S, Saubermann, L J, & Strober, W (1999). Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Current Opinion in Immunology, 11 648-656.
61. Wirtz, S, & Neurath, M F (2000). Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. International Journal of Colorectal Disease, 15 144-160.
62. Kosiewicz, M M, Nast, C C, & Krishnan, A et al. (2001). Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. Journal of Clinical Investigation, 107 695-702.
63. + T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. Journal of Experimental Medicine, 187 855-864.
64. Madsen, K L, Doyle, J S, & Jewell, L D et al. (1999). Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology, 116 1107-1114.
65. O'Mahony, L, Feeney, M, & O'Halloran, S et al. (2001). Probiotic impact on microbial flora inflammation and tumor development in IL-10 knock out mice. Alimentary Pharmacology and Therapeutics, 15 1219-1225.
66. Duchmann, R, Kaiser, I, & Hermann, E et al. (1995). Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clinical and Experimental Immunology, 102 448-455.
67. Duchmann, R, Schmitt, E, & Knolle, P et al. (1996). Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. European Journal of Immunology, 26 934-938.
68. Duchmann, R, May, E, & Heike, M et al. (1999). T cell specificity and cross reactivity toward enterobacteria, Bacteroides, Bifidobacterium, and antigens from resident intestinal flora in humans. Gut, 44 812-818.
69. MacPherson, A, Khoo, U Y, & Forgacs, I et al. (1996). Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut, 38 365-375.
70. Shanahan, F, & Bernstein, C (1993). Odd forms of inflammatory bowel disease - what can they tell us?. Gastroenterology, 104 327-329.
71. Harper, P H, Lee, E CG, & Kettlewell, M GW et al. (1985). Role of the faecal stream in the maintenance of Crohn's colitis. Gut, 26 279-284.
72. D'Haens, G R, Geboes, K, & Peeters, M et al. (1998). Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology, 114 262-267.
73. Schultsz, C, Van Den Berg, F, & Ten Kate, F W et al. (1999). The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology, 117 1089-1097.
74. Darfeuille-Michaud, A, Neut, C, & Barnich, N et al. (1998). Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology, 115 1405-1413.
75. Swidinski, A, Ladhoff, A, & Pernthaler, A et al. (2002). Mucosal flora in inflammatory bowel disease. Gastroenterology, 122 44-54.
76. Braun, J (2002). Unsettling facts of life: bacterial commensalism, epithelial adherence, and inflammatory bowel disease. Gastroenterology, 122 228-230.
77. Glasser, A- L, Boudeau, J, & Barnich, N et al. (2001). Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infection and Immunity, 69 5529-5537.
78. Fox, J G (2002). The non- H. pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut, 50 273-283.
79. Hugot, J P, Chamaillard, M, & Zouali, H et al. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411 599-603.
80. Ogura, Y, Bonen, D K, & Inohara, N et al. (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411 603-606.
81. Lawrence, T, Gilroy, D W, Colville-Nash, P R, & Willoughby, D A (2001). Possible new role for NF-κB in the resolution of inflammation. Nature Medicine, 7 1291-1297.
82. Gionchietti, P, Rizzello, F, & Venturi, A et al. (2000). Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double blind, placebo-controlled trial. Gastroenterology, 119 305-309.
83. + lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nature Medicine, 5 1178-1182.
84. Tysk, C, Lindberg, E, Jarnerot, G, & Floderus-Myrhed, B (1988). Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut, 29 990-996.
85. Gent, A E, Hellier, M D, & Grace, R H et al. (1994). Inflammatory bowel disease and domestic hygiene in infancy. Lancet, 343 766-767.
86. Elliott, D E, Urban, Jr. J F, Argo, C K, & Weinstock, J V (2000). Does the failure to acquire helminthic parasites predispose to Crohn's disease?. FASEB Journal, 14 1848-1855.
87. Keane, J, Gershon, F, & Wise, R P et al. (2001). Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralising agent. New England Journal of Medicine, 345 1098-1104.
88. Robertson, D J, & Sandler, R S (2001). Measles virus and Crohn's disease: a critical appraisal of the current literature. Inflammatory Bowel Disease, 7 51-57.
89. Taylor, K, D, Rotter, J, I, Yang, H, Genetics of inflammatory bowel disease, In Targan, S, RShanahan, FKarp, L, C, (Eds.), Inflammatory Bowel Disease: From Bench to Bedside, 2nd edn. Dordrecht, Kluwer Academic (in press)
90. Report of a Joint FAO/WHO Expert Consultation. Health and nutritional properties of probiotics in food including powder milk and live lactic acid bacteria, http://www.fao.org/es/ESN/Probio/report. Accessed 2001.
91. Dunne, C, & Shanahan, F (2002). Role of probiotics in the treatment of intestinal infections and inflammation. Current Opinion in Gastroenterology, 18 40-45.
92. Kruis, W, Schütz, E, & Fric, P et al. (1997). Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Alimentary Pharmacology and Therapeutics, 11 853-858.
93. Rembacken, B J, Snelling, A M, & Hawkey, P M et al. (1999). Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet, 354 635-639.
94. Collins, J K, Murphy, L, & Morrissey, D et al. (2002). A randomised controlled trial of a probiotic Lactobacillus strain in healthy adults: assessment of its delivery, transit, and influence on microbial flora and enteric immunity. Microbial Ecology in Health and Disease, 14 81-89.
95. Dunne, C, Murphy, L, & Flynn, S et al. (1999). Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie von Leeuwenhook, 76 279-292.
96. Steidler, L, Hans, W, & Schotte, L et al. (2000). Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science, 289 1352-1355.
97. Shanahan, F (2000). Therapeutic manipulation of gut flora. Science, 289 1311-1312.